IDEXX Laboratories
In Chris Tsai's portfolio · Tsai Capital
Ticker IDXX
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Tsai Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Sell | 0 | |
| Q1 2026 | Add 2% | 4,782 | 2.0% |
| Q4 2025 | Add 1% | 4,678 | 2.2% |
| Q3 2025 | No change | 4,642 | 2.1% |
| Q2 2025 | Reduce 50% | 4,640 | 1.8% |
| Q1 2025 | Add 5% | 9,225 | 3.2% |
| Q4 2024 | Add 52% | 8,797 | 2.6% |
| Q3 2024 | Add 13% | 5,781 | 2.4% |
| Q2 2024 | No change | 5,127 | 2.5% |
| Q1 2024 | Reduce 3% | 5,127 | 2.9% |
| Q4 2023 | Reduce 6% | 5,285 | 2.7% |
| Q3 2023 | No change | 5,632 | 2.4% |
| Q2 2023 | Add 3% | 5,632 | 2.6% |
| Q1 2023 | Reduce 17% | 5,492 | 2.9% |
| Q4 2022 | Reduce 7% | 6,608 | 3.9% |
| Q3 2022 | No change | 7,079 | 2.6% |
| Q2 2022 | Buy | 7,079 | 2.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.